Back
Sinopharm Group Vs. CASI Pharmaceuticals Industry Stock Comparison
Buy
53
SHTDY
Sinopharm Group
Last Price:
13.24
Seasonality Move:
-4.58%
Sell
24
CASI
CASI Pharmaceuticals
Last Price:
2.65
Seasonality Move:
-16.04%
Buy
53
Sinopharm Group (SHTDY)
is a Buy
Is Sinopharm Group a Buy, Sell or Hold?
- The current Sinopharm Group [SHTDY] share price is $13.24. The Score for SHTDY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SHTDY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
CASI Pharmaceuticals (CASI)
is a Sell
Is CASI Pharmaceuticals a Buy, Sell or Hold?
- The current CASI Pharmaceuticals [CASI] share price is $2.64. The Score for CASI is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- CASI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SHTDY Stock Price Chart
What is Sinopharm Group's stock price today?
-
The Sinopharm Group share price today is $13.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SHTDY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CASI Stock Price Chart
What is CASI Pharmaceuticals's stock price today?
-
The CASI Pharmaceuticals share price today is $2.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing selling pressure, which indicates risk of future bearish movement.
SHTDY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 54.51 | Buy |
| Chaikin Money Flow: | 4638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.41 - 13.31) | Buy |
| Bollinger Bands (100): | (12.41 - 13.65) | Buy |
CASI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 44.94 | Sell |
| Chaikin Money Flow: | -1698 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.29 - 2.93) | Buy |
| Bollinger Bands (100): | (3.08 - 6.48) | Sell |
SHTDY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.79 | Buy |
| 20-day SMA: | 12.89 | Buy |
| 50-day SMA: | 13.14 | Buy |
| 200-day SMA: | 13.23 | Buy |
| 8-day EMA: | 12.96 | Buy |
| 20-day EMA: | 12.95 | Buy |
| 50-day EMA: | 13.03 | Buy |
| 200-day EMA: | 13.27 | Sell |
CASI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.57 | Buy |
| 20-day SMA: | 2.47 | Buy |
| 50-day SMA: | 3.33 | Sell |
| 200-day SMA: | 4.08 | Sell |
| 8-day EMA: | 2.6 | Buy |
| 20-day EMA: | 2.65 | Sell |
| 50-day EMA: | 3.31 | Sell |
| 200-day EMA: | 4 | Sell |
Sinopharm Group Earnings Growth & SHTDY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CASI Pharmaceuticals Earnings Growth & CASI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
Sinopharm Group Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CASI Pharmaceuticals Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||